LTR Pharma Limited (ASX:LTP)
Australia flag Australia · Delayed Price · Currency is AUD
0.4650
0.00 (0.00%)
Last updated: Sep 11, 2026, 10:37 AM AEST

LTR Pharma Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.720.721.510.05-0.01
Revenue Growth
-36.02%-52.01%2978.25%---
Gross Profit
-5.97-5.97-1.28-3.46-0.01
Operating Income
-13.99-13.99-6.11-6.94-1.44-1.02
Net Income
-14.16-14.16-5.59-6.95-1.45-1.03
Earnings Per Share
-0.08-0.08-0.03-0.05-0.01-
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
19.6619.6631.813.11.731.91
Total Debt
------
Net Cash (Debt)
19.6619.6631.813.11.731.91
Net Cash Growth
-23.73%-38.19%925.31%79.46%-9.56%-
Net Cash Per Share
0.110.110.190.020.01-

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-10.84-10.84-4.44-5.09-1.54-0.57
Capital Expenditures
-0.01-0.01-0.01-0-0-
Free Cash Flow
-10.85-10.85-4.45-5.09-1.54-0.57
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
---84.75%--100.00%
Operating Margin
-1932.77%-1932.77%-404.86%-14162.27%--11195.03%
Pretax Margin
-1956.57%-1956.57%-370.83%-14192.25%--11314.40%
Profit Margin
-1956.57%-1956.57%-370.83%-14192.25%--11314.40%
FCF Margin
-1498.07%-1498.07%-294.96%-10396.58%--6258.86%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
116.76136.8534.792219.25--